Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
April 26, 1994 - May 10, 1994
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guidelineopen allclose all
according to guideline
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
according to guideline
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
Trisodium bis[(3'-nitro-5'-sulfonato-(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)
EC Number:
EC Name:
Trisodium bis[(3'-nitro-5'-sulfonato-(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)
Molecular formula:
chromium(3+) trisodium bis(6-amino-2-{4-[2-(2-hydroxynaphthalen-1-yl)diazen-1-yl]benzenesulfonamido}-5-[2-(3-nitro-2-oxido-5-sulfonatophenyl)diazen-1-yl]pyrimidin-4-olate)
Test material form:
solid: particulate/powder

Test animals

Details on test animals or test system and environmental conditions:
- Source: BRL, Biological Research Laboratories Ltd., Wñlferstrasse 4, CH-4414 Füllinsdorf/Switzerland
- Age at study initiation: males at 9 weeks; females at 11 weeks
- Weight at study initiation: males at 256.0 - 269.6; females at 189.0 - 209.7 g
- Diet: pelleted standard Kliba 343. Batch nos. 86/93 and 87/93 rat maintenance diet ("Kliba", Klingentalmuehle AG, CH-4303 Kaiseraugst) available ad libitum (except for over-night fasting period prior to application).
- Water: community tap water from Fülllnsdorf, available ad libitum.
- Acclimation period: one week under laboratory conditions» after health examination. Only animals without any visual signs of illness were used for the study.
- Identification: by unique cage number and corresponding color-coded spots on the tail.
- Randomization: randomly selected at time of delivery Into groups of five

- Temperature: continuously monitored environment with a temperature of 22 ± 2 °C
- Humidity: 36 - 64 %
- Air changes: 10-15 ACH
- Photoperiod: 12 hours artificial fluorescent light (approx. 100 Lux) / 12 hours dark (light period between 6.00 a.m. to 6.00 p.m.), music during the light period
- Cage: during acclimatization in groups of five in Makrolon type-4 cages (size: 33 x 55 x 20 cm) with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz); during treatment and observation individually in Makrolon type-3 cages (size: 22 X 37.5 x 15 cm) with standard softwood bedding.

Administration / exposure

Type of coverage:
Details on dermal exposure:
- Area of exposure: approximately 24 hours before treatment, the backs of the animals were clipped with an electric clipper. On test day 1, the test article was applied at a dose of 2000 mg/kg body weight evenly on the intact skin with a syringe.
- % coverage: area of approximately 10 % of the total body surface.
- Type of wrap if used: semi-occlusive dressing. The dressing was wrapped around the abdomen and fixed with an elastic adhesive bandage.
- Rationale: dermal administration was used because this is one possible route of human exposure during manufacture, handling and use of the test article.

- Washing: the skin was washed with lukewarm tap water and dried with disposable paper towels.
- Time after start of exposure: twenty-four hours after the application.

- Amount applied: 4.0 ml/kg
- For solids, paste formed: no
- Preparation: the test article was placed into a glass beaker on a tared Mettier PM 480 balance, and the vehicle, (bi-distilled water) was added. A weight by volume dilution was prepared using a homogenizer (Ultra-Turrax, Janke & Kunkel, D-79219 Staufen).
Homogeneity of the test article in the vehicle was maintained during treatment using a magnetic stirrer (Janke & Kunkel, D-79219 Staufen).
The preparation was made shortly before dosing.
Duration of exposure:
24 hours
2000 mg/kg bw, single dose
No. of animals per sex per dose:
5 males and 5 females
Control animals:
Details on study design:
- Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: on test day 1 (pre-administration), 8 and 15.
- Necropsy: necropsies were performed by experienced prosectors. At the end of the observation period all animals were anesthetized by intraperitoneal injection of NARCOREN at a dose of at least 2.0 ml/kg body weight and sacrificed by exsanguination. The animals were examined macroscopically.
- Other examinations performed: each animal was examined for changes in behaviour and appearance (with special emphasis on the application area, except for the time when the semi-occlusive dressing was in place) four times during day 1, and once dally during days 2-15.
The LOGIT-Model could not be used as no deaths occurred,

Results and discussion

Effect levels
Dose descriptor:
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Value not quantified since higher than tested concentrations
No deaths observed.
Clinical signs:
other: No clinical signs of systemic toxicity.
Gross pathology:
No organ abnormalities were observed at necropsy.
Other findings:
A red discoloration of the skin at the application site was evident in all animals after the removal of the dressing on test day 2 and persisted until test day 3 - 6.

Applicant's summary and conclusion

Interpretation of results:
other: not classified according to the CLP Regulation (EC 1272/2008)
LD50 (males and females) > 2000 mg/kg b.w.
Executive summary:

The test article was administered to a group of 5 male and 5 female rats by semi-occlusive dermal application with a single dose of 2000 mg test article/kg body weight.

- No deaths occurred during the study period.

- No clinical signs of systemic toxicity were observed during the observation period.

- A red discoloration of the skin at the application site was evident in all animals after the removal of the dressing on test day 2 and persisted until test day 3 - 6.

- There were no test article-related effects on the body weight of the animals during the observation period. The slight reduction in body weight gain during the first observation week was considered to be a consequence of the semi occlusive dressing.

- The macroscopic examination at study termination revealed no organ abnormalities.

In conclusion, the mean lethal dose after single oral administration to rats of both sexes, observed over a period of 14 days, could not be estimated, because no deaths occurred at the maximal dose of 2000 mg test article/kg body weight.